Just days after Johnson & Johnson's Children's Tylenol started returning to store shelves, the health care giant has recalled about four million packages of Children's Benadryl allergy tablets and some 800,000 bottles of Junior Strength Motrin, citing manufacturing problems.
In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.
CEO William Weldon will apologize to Congress for a series of product recalls over the past year. The company is also expected to resume shipments of children's cold medication next week.
Johnson & Johnson subsidiary McNeil recalled another batch of over-the-counter medicines Thursday. The specific lots of Tylenol, Motrin and Benadryl products may have been contaminated with trace amounts of a chemical that gives them a musty or moldy odor.
A House panel will hold a second hearing, postponed until sometime after June 30, to examine the recall of more than 135 million bottles of infant and children's medicines produced by J&J's McNeil Consumer Healthcare unit. This time the boss is expected to show.